The acquisition will integrate MedEuropa’s expertise in cancer care into Affidea’s Romanian operations. Credit: PeopleImages.com – Yuri A / Shutterstock.

Advanced diagnostics and multi-speciality polyclinics provider Affidea Group has signed a binding agreement for the acquisition of MedEuropa Romania, enhancing its cancer treatment services in the country.

The deal is pending Romanian Competition Council approval.

Both parties did not disclose the financial terms of the deal.

This strategic acquisition marks a significant expansion of Affidea’s services in Romania, adding advanced radiotherapy to its extensive portfolio.

MedEuropa, established by Telemos Capital in collaboration with regional entrepreneurs, focuses on addressing the under-supplied Romanian radiotherapy market.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Tick here to opt out of curated industry news, reports, and event updates from Hospital Management.

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It runs four medical centres across Romania, located in Constanta, Bucharest, Brasov, and Oradea.

MedEuropa is also planning two additional centres in Iasi and Bacau this year.

This expansion aligns with the current diagnostic and polyclinic services of Affidea in Romania to create a more comprehensive healthcare offering.

The acquisition will integrate MedEuropa’s expertise in cancer care into Affidea’s Romanian operations, which currently include 50 medical centres in 26 cities.

Affidea Romania employs over 1,500 staff, including more than 900 clinicians, and provides integrated medical services to over two million patients annually.

Rizoiu & Asociatii and Clifford Chance are serving as the legal advisors for Affidea Group while Deloitte is the financial advisor.

Biris Goran and Linklaters are MedEuropa’s legal advisors.

Affidea Romania and Hungary country CEO Razvan Predica said: “Cancer is claiming far too many lives in our communities, with approximately 100,000 people being diagnosed with an oncological disease in Romania every year.

“This acquisition isn’t just about growth; it’s about standing shoulder-to-shoulder with the National Health System and those affected by this relentless disease.

“We look forward to working with the great team of MedEuropa following the closing and continue delivering value for every individual impacted by cancer by increasing access to a more comprehensive cancer care pathway from diagnosis to treatment and follow-up.”